Matinas Biopharma Holdings Inc (MTNB)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Matinas BioPharma Pioneers Revolutionary Oral Therapy for Invasive Fungal Infections
MAT2203: Promising Breakthrough in Treating Invasive Fusarium Infections
A Blowout performance, by the Matinas Biopharma Holdings Inc all along the second quarter of 2022
A deficit of $-0.03 per Share at the MTNB in financial span ending September 30 2021